Saven Technologies Ltd
₹33.45
+1.23 (3.82%)
Fri, 06 Nov 2026, 08:54 pm
Saven Technologies News
Saven Tech Q2FY27: PAT jumps 34% YoY
Saven Technologies reported a 34% YoY rise in net profit to ₹102.74 lakh for Q2FY27, driven by 15% revenue growth. However, half-year profits declined due to lower other income.
05 Nov 2026
companies
Saven Technologies concludes 33rd AGM
Saven Technologies Limited held its 33rd AGM on September 24, 2026, via video conference. Key resolutions included adopting FY26 financials and confirming an interim dividend of ₹1.50 per share.
24 Sept 2026
companies
Saven Technologies Q1FY27 Results
Saven Technologies reports a 44.6% YoY drop in net profit to ₹75.35 lakh for Q1FY27, despite an 7.5% rise in revenue to ₹485.54 lakh.
30 Jul 2026
companies
Saven Technologies closes trading window for Q1FY26
Saven Technologies Limited has closed its trading window from July 1, 2026, until the declaration of Q1FY26 results. The restriction applies to directors and employees to prevent insider trading.
23 Jun 2026
companies
Saven Technologies Audited Results
Saven Technologies Limited published audited financial results for the quarter and year ended March 31, 2026. The results were disclosed in newspapers on May 23, 2026.
23 May 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo